Patents Assigned to Cantocor, Inc.
  • Methods and compositions for enhanced protein expression and/or growth of cultured cells using co-transcription of a Bcl2 encoding nucleic acid
    Patent number: 6964199
    Abstract: The present invention in the field of biotechnology, provides methods and compositions for providing enhanced growth of, and/or protein production from, cultured mammalian host cells used for the production of commercially useful amounts of expressed proteins, by the use of at least one Bcl2 encoding nucleic acid provided or transcribed in the host cell.
    Type: Grant
    Filed: November 2, 2001
    Date of Patent: November 15, 2005
    Assignee: Cantocor, Inc.
    Inventors: ChiChang Lee, Xiaomei Shi, Celia Ly, Gordon Moore
  • Use of a clathrate modifier, to promote passage of proteins during nanofiltration
    Patent number: 6773600
    Abstract: The invention relates to the field of protein purification and the recovery of large proteinaceous material through small, nanometer sized, pore exclusion filters for removal of contaminants such as viral pathogens.
    Type: Grant
    Filed: June 4, 2003
    Date of Patent: August 10, 2004
    Assignee: Cantocor, Inc.
    Inventors: Barry P. Rosenblatt, Richard C. Siegel